STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher C Moore, MD
University of Virginia
Principal Investigator - Scott K Heysell, MD, MPH
University of Virginia
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sekou Toure Regional Referral Hospital
Mwanza, Tanzania
Frederick C Mwita, MD - Kibong'Oto Infectious Diseases Hospital
Sanya Juu, Tanzania
Stellah G Mpagama, MD, PhD
- Fort Portal Regional Referral Hospital
Fort Portal, Uganda
Dalton K Munyambalu, MBChB, MMed - Mbarara Regional Referral Hospital
Mbarara, Uganda
Edwin Nuwagira, MBChB, MMed
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2026
- Primary completion
- 31 Mar 2029
- Completion
- 30 Sept 2029
- Last update posted
- 1 Jun 2026
- Registered enrollment
- 344
- Registry id
- NCT07332325
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.